Suchergebnisse - "Kugener, Luc"

PubPharm (18)

1

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation : consider the potential influence of corticosteroid therapy

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Aug 28;24(1):530. - PMID 32859241

2

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

3

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

4

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19 : perhaps some potential confounders to consider

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Jul 17;24(1):444. - PMID 32680535

5

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

6

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

7

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes : fact or fiction?

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Aug 4;24(1):481. - PMID 32753056

8

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

9

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

10

Inhibiting IL-6 in COVID-19 : we are not sure

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Jun 11;24(1):331. - PMID 32527304